Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Turner

Dermatology Bartlett, TN Medical Doctor

NPI 1528083706 CMS profile 341183

6644 Summer Knoll Cir, Bartlett, TN 38134

Open in the dashboard

General payments

$314,155

812 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$6,660 paid to institutions, not to them · program years 2019–2021

Through program year 2025, James Turner of Bartlett, TN is reported in the CMS Open Payments database as having received $314,155 across 812 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $6,660 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $820 6
2024 General $1,255 10
2023 General $2,032 8
2022 General $1,364 10
2021 General $1,102 10
2020 General $48,303 144
2019 General $259,278 624

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Turner
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to James Turner were reported at $820. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year James Turner Dermatology median Middle half National median
2019 $259,278 $454 $129–$1,240 $163
2020 $48,303 $235 $81–$756 $114
2021 $1,102 $377 $108–$1,108 $132
2022 $1,364 $514 $143–$1,391 $149
2023 $2,032 $607 $159–$1,674 $160
2024 $1,255 $751 $204–$1,903 $164
2025 $820 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sun Pharmaceutical Industries Inc. $98,299 106 payments
  2. Celgene Corporation $89,452 99 payments
  3. Amgen Inc. $50,137 73 payments
  4. UCB, Inc. $28,275 59 payments
  5. Ortho Dermatologics, a division of Bausch Health US, LLC $18,657 45 payments
  6. AbbVie, Inc. $11,169 89 payments
  7. Janssen Biotech, Inc. $7,092 25 payments
  8. Lilly USA, LLC $3,251 24 payments
  9. Allergan Inc. $2,983 25 payments
  10. Helsinn Therapeutics (U.S.), Inc. $1,482 1 payment
  11. Other $3,356 266 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $144,497 76 payments
  2. Honoraria $87,600 20 payments
  3. Consulting Fee $27,261 13 payments
  4. Travel and Lodging $26,525 131 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $14,920 5 payments
  6. Food and Beverage $13,351 567 payments
Products named General payments · program years 2019–2025
  1. ILUMYA $92,727 84 payments
  2. Otezla Dermatology $89,296 78 payments
  3. Otezla Inflammation $28,415 42 payments
  4. Cimzia $28,275 59 payments
  5. Otezla Inflammation $21,636 21 payments
  6. DUOBRII $13,817 26 payments
  7. TREMFYA $6,964 15 payments
  8. HUMIRA $6,491 61 payments
  9. Odomzo $5,379 11 payments
  10. SILIQ $4,768 13 payments
  11. Other $11,967 568 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

812 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record